Pfizer · NSE: PFIZER · BSE: 500680
Q1 FY27 results · Apr–Jun 2026
Pfizer reported revenue from operations of ₹653.17 crore (up 8.3% from Q1 FY26) and net profit of ₹204.47 crore (up 6.6% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a standalone basis.
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 653.17 | 603.05 | +8.3% | 629.23 | +3.8% |
| Other income | 44.84 | 67.17 | −33.2% | 40.72 | +10.1% |
| Total income | 698.01 | 670.22 | +4.1% | 669.95 | +4.2% |
| Profit before tax | 276.68 | 259.53 | +6.6% | 268.82 | +2.9% |
| Net profit for the period | 204.47 | 191.75 | +6.6% | 199.82 | +2.3% |
| EPS, basic (₹) | 44.69 | 41.91 | +6.6% | 43.68 | +2.3% |
| Net margin (%) | 31.3 | 31.8 | 31.8 |
Standalone
- Filed with BSE
- 28 Jul 2026, 18:56 IST
- Board meeting
- 28 Jul 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE